AGP Picks
View all

Catch up with telecommunications news from the world

Provided by AGP

Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on May 15, 2026

Bread Financial Provides Performance Update for April 2026
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation
Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology
Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results
Base Carbon Reports First-Quarter 2026 Operating and Financial Results
Edible Garden Reports 22.9% First Quarter 2026 Revenue Growth and Advancement of Ready-to-Drink (RTD) Nutrition Platform
KOIL Energy Reports First Quarter 2026 Results
Profusa Announces Listing Transfer to The Nasdaq Capital Market
Intercontinental ICU Air Ambulance Transport Highlights Growing Need for Continuous In-Flight Medical Care
"2026 Global Mayors Dialogue · Chengdu" Opens a New Chapter in City Diplomacy
Davos Alzheimer’s Collaborative Celebrates Andrea Pfeifer, Retiring CEO of AC Immune, for Her Contributions to Alzheimer’s Policy, Research and Care
Quantum Cyber Launches quantum-cyber.ai Targeting Homeland Security, Autonomous Drone, and Quantum Technology Sectors
Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder
Nobel Provides Update on Pampa Austral Drilling and Cuprita Project, Chile
Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:

Sign up for:

Telecoms Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.